These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

172 related articles for article (PubMed ID: 27305069)

  • 1. Two new amphetamines for ADHD.
    Med Lett Drugs Ther; 2016 Jun; 58(1497):80-1. PubMed ID: 27305069
    [No Abstract]   [Full Text] [Related]  

  • 2. Cotempla XR-ODT--another long-acting methylphenidate for ADHD.
    Med Lett Drugs Ther; 2017 Nov; 59(1533):183-185. PubMed ID: 29125594
    [No Abstract]   [Full Text] [Related]  

  • 3. Central stimulants in the treatment of attention-deficit hyperactivity disorder (ADHD) in children and adolescents. A naturalistic study of the prescription in Sweden, 1977-2007.
    Janols LO; Liliemark J; Klintberg K; von Knorring AL
    Nord J Psychiatry; 2009 Nov; 63(6):508-16. PubMed ID: 19958258
    [TBL] [Abstract][Full Text] [Related]  

  • 4. QuilliChew ER--extended-release chewable methylphenidate tablets.
    Med Lett Drugs Ther; 2016 May; 58(1495):68-9. PubMed ID: 27192619
    [No Abstract]   [Full Text] [Related]  

  • 5. Pharmacokinetics of a Novel Amphetamine Extended-Release Orally Disintegrating Tablet in Children with Attention-Deficit/Hyperactivity Disorder.
    Stark JG; Engelking D; McMahen R; Sikes C
    J Child Adolesc Psychopharmacol; 2017 Apr; 27(3):216-222. PubMed ID: 27936898
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A new amphetamine oral suspension (Adzenys ER) for ADHD.
    Med Lett Drugs Ther; 2018 Jun; 60(1549):e106-e108. PubMed ID: 29913476
    [No Abstract]   [Full Text] [Related]  

  • 7. Mixed amphetamine salts extended release for the treatment of ADHD.
    Biederman J
    CNS Spectr; 2005 Dec; 10(12 Suppl 20):5. PubMed ID: 16344840
    [No Abstract]   [Full Text] [Related]  

  • 8. Relative benefits of stimulant therapy with OROS methylphenidate versus mixed amphetamine salts extended release in improving the driving performance of adolescent drivers with attention-deficit/hyperactivity disorder.
    Cox DJ; Merkel RL; Moore M; Thorndike F; Muller C; Kovatchev B
    Pediatrics; 2006 Sep; 118(3):e704-10. PubMed ID: 16950962
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Medication for ADHD and the risk of cardiovascular mortality].
    Kalverdijk LJ; Buitelaar JK; van der Gaag RJ
    Ned Tijdschr Geneeskd; 2006 Oct; 150(41):2283-4; author reply 2284. PubMed ID: 17078147
    [No Abstract]   [Full Text] [Related]  

  • 10. Effectiveness of one-year pharmacological treatment of adult attention-deficit/hyperactivity disorder (ADHD): an open-label prospective study of time in treatment, dose, side-effects and comorbidity.
    Fredriksen M; Dahl AA; Martinsen EW; Klungsøyr O; Haavik J; Peleikis DE
    Eur Neuropsychopharmacol; 2014 Dec; 24(12):1873-84. PubMed ID: 25453480
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Pharmacokinetics of a New Amphetamine Extended-Release Oral Suspension in Children with Attention-Deficit/Hyperactivity Disorder.
    Sikes CR; McMahen RL; Stark JG; Engelking D
    J Child Adolesc Psychopharmacol; 2018 Feb; 28(1):29-35. PubMed ID: 28933918
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Attention deficit hyperactivity disorder in adults.
    Rösler M; Casas M; Konofal E; Buitelaar J
    World J Biol Psychiatry; 2010 Aug; 11(5):684-98. PubMed ID: 20521876
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Coming into focus. Pharmacologic treatment for ADHD.
    McDonnell MA; Moffett C
    Adv NPs PAs; 2010 Dec; 1(4):16-22; quiz 23. PubMed ID: 21319448
    [No Abstract]   [Full Text] [Related]  

  • 14. Focalin XR for ADHD.
    Med Lett Drugs Ther; 2009 Mar; 51(1308):22-4. PubMed ID: 19305368
    [No Abstract]   [Full Text] [Related]  

  • 15. Attention-deficit/hyperactivity disorder, stimulants, statistics, and methodology.
    Poulton A
    J Child Adolesc Psychopharmacol; 2006 Aug; 16(4):507-8. PubMed ID: 16958579
    [No Abstract]   [Full Text] [Related]  

  • 16. [Efficacy and safety of stimulants and non-stimulants in adults with attention deficit hyperactivity disorder (ADHD)].
    Golubchik P; Sever J; Weizman A
    Harefuah; 2011 Oct; 150(10):788-90, 814. PubMed ID: 22111124
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Treating adult ADHD with stimulants.
    Stein MA
    CNS Spectr; 2008 Sep; 13(9 Suppl 13):8-11. PubMed ID: 18849904
    [No Abstract]   [Full Text] [Related]  

  • 18. [How safe are ADHD drugs?].
    Schwarz R; Muskalla B
    Kinderkrankenschwester; 2005 Oct; 24(10):437. PubMed ID: 16262203
    [No Abstract]   [Full Text] [Related]  

  • 19. [Apropos the National Board and Welfare's report on ADDH: some views on the treatment with central nervous system stimulants].
    Zetterström R
    Lakartidningen; 2002 Aug; 99(35):3435-6. PubMed ID: 12362770
    [No Abstract]   [Full Text] [Related]  

  • 20. Amphetamine salt compound treatment for adults with attention deficit hyperactivity disorder.
    Newcorn JH
    Curr Psychiatry Rep; 2002 Apr; 4(2):85-6. PubMed ID: 11914167
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 9.